Search

Author/Creator Turan, Merve

2. Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study. (7th February 2022)

Authors:
Bilici, Ahmet; Uysal, Mukremin; Menekse, Serkan; Akin, Semih; Yildiz, Fatih; Turan, Merve; Sezgin Goksu, Sema; Beypinar, Ismail; Sakalar, Teoman; Değirmenci, Mustafa; Erdem, Dilek; Basaran, Gul; Olmez, Omer Fatih; Avci, Nilufer; Tural, Deniz; Sakin, Abdullah; Turker, Sema; Demir, Atakan; Temiz, S...
Journal:
Cancer investigation
Issue:
Volume 40:Number 2(2022)
Page Start:
199
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer. (April 2021)

Authors:
Tataroglu Ozyukseler, Deniz; Basak, Mustafa; Ay, Seval; Koseoglu, Aygül; Arıcı, Serdar; Oyman, Abdilkerim; Sürmeli, Heves; Turan, Merve; Turan, Nedim; Odabaş, Hatice; E Yıldırım, Mahmut
Journal:
Journal of oncology pharmacy practice
Issue:
Volume 27:Number 3(2021)
Page Start:
547
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗